Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Viewers & Players | What's New | Browse | Información en español | E-mail Updates   E-mail Updates
www.ahrq.gov
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
spacer
 MEPS Home
 About MEPS
 :: Survey Background
 :: Workshops & Events
 :: Data Release Schedule
 Survey Components
 :: Household
 :: Insurance/Employer
 :: Medical Provider
 :: Survey Questionnaires
 Data and Statistics
 :: Data Overview
 :: MEPS Topics
 :: Publications Search
 :: Summary Data Tables
 :: MEPSnet Query Tools
 :: Data Files
 :: Data Centers
 Communication
 :: What's New
 :: Mailing List
 :: Discussion Forum
 :: Participants' Corner

   
MEPS Topics: Prescription Drugs
Click here for full topic list.
""
Prescription Drugs
Description: MEPS-HC survey participants are asked about their prescription drugs and then are asked for permission to collect more detailed information from their pharmacies. At the pharmacies, data are collected on the type, dosage, and payment for each filled prescription. No information is collected for over-the-counter medications. No information is collected for prescription drugs obtained during hospital visits.
Data tables: The HC Summary Data Tables include prescription drugs data for overall expenditure and utilization (Total Medical Expenditures), expenditure and utilization by medical conditions (Expenditures by Medical Conditions), and the top 10 drugs (Prescription Drugs).
Analytic tools: You can use the MEPSnet/HC query tool to generate your own estimates by selecting prescription drug expenditures. Select the Prescribed Medicines variables within the Utilization, Expenditures, and SOP Variable Group categoryof the Variable Selection Query Tab.
Audioicon AHRQ Podcasts: Healthcare 411 Series: Cholesterol Levels 02:00 (MM:SS)
Healthcare 411 Series: Brand-name Drugs Increased Overall Spending for Prescription Drugs 01:00 (MM:SS)
Publications: Publications are listed in reverse chronological order (most recent first).
Expenditures for Commonly Treated Conditions among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2013 
Statistical Brief #487 
Trends in Prescribed Outpatient Opioid Use and Expenses in the U.S. Civilian Noninstitutionalized Population, 2002-2012 
Statistical Brief #478 
Behavioral Medication Utilization in Children and Teenagers Ages 5-18 in the U.S. Civilian Noninstitutionalized Population, 2012 
Statistical Brief #473 
Top Five Most Costly Conditions among Children, Ages 0-17, 2012: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #472 
Top Five Most Costly Conditions among Adults Age 18 and Older, 2012: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #471 
Trends in the Five Most Costly Conditions among the U.S. Civilian Noninstitutionalized Population, 2002 and 2012 
Statistical Brief #470 
Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Medicare Beneficiaries, Age 65 and Older, U.S. Civilian Noninstitutionalized Population, 2012 
Statistical Brief #469 
Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and Older, U.S. Civilian Noninstitutionalized Population, 2012 
Statistical Brief #468 
Changes in Statin Therapy among Adults (Age ≥ 18) by Selected Characteristics, United States, 2000–2001 to 2010–2011 
Statistical Brief #459 
Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011 
Statistical Brief #458 
Changes in Osteoporosis Medication Use and Expenditures among Women (Age ≥ 50), United States, 2000 to 2011 
Statistical Brief #442 
Trends in Use and Expenditures for Cancer Treatment among Adults 18 and Older, U.S. Civilian Noninstitutionalized Population, 2001 and 2011 
Statistical Brief #443 
Outpatient Prescription Drugs: Data Collection and Editing in the 2011 Medical Expenditure Panel Survey 
Methodology Report #29 
Trends in Antidepressant Utilization and Expenditures in the U.S. Civilian Noninstitutionalized Population by Age, 2000 and 2010 
Statistical Brief #430 
Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Medicare Beneficiaries, Age 65 and Older, U.S. Civilian Noninstitutionalized Population, 2010 
Statistical Brief #411 
Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and Older, U.S. Civilian Noninstitutionalized Population, 2010 
Statistical Brief #410 
Trends in Urinary Antispasmodics Utilization and Expenditures for the U.S. Civilian Noninstitutionalized Population, 2000 and 2010 
Statistical Brief #400 
Expenditures for Trauma-Related Disorders among the Elderly and Non-Elderly, 2009: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #397 
National Health Care Expenses in the U.S. Civilian Noninstitutionalized Population, 2010 
Statistical Brief #396 
Expenditures for Heart Disease among Adults Age 18 and Older: Estimates for the U.S. Civilian Noninstitutionalized Population, 2009 
Statistical Brief #393 
1 to 20 of 107   >>Next>>
 
   Page last revised:  October 5, 2009
MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . COPYRIGHT